Topic animation: Long-term data in multiple sclerosis

Multiple sclerosis is a lifelong disease that requires long-term treatment with disease-modifying therapy. Randomised controlled trials (RCTs) are considered the gold standard for measuring the safety and efficacy of these treatments. However, distinct patient inclusion criteria and limited follow-up times mean that results from RCTs can not always be extrapolated to real-world conditions. This